Oct. 7, 2021—When the COVID-19 pandemic shut down international travel necessary for overseas medical initiatives, Vanderbilt's Rondi Kauffmann, MD, MPH, began brainstorming ways to extend surgical care to those in need much closer to home.
Oct. 6, 2021— by Jessica Pasley More than 195 cases of multi-system inflammatory syndrome in children (MIS-C) have been reported statewide since May 2020, according to Tennessee Department of Health data. The number of cases has more than tripled since early February when the Center for Disease Control and Prevention (CDC) showed about 51 cases in Tennessee....
Oct. 5, 2021—Biopharmaceutical company AstraZeneca has requested emergency use authorization (EUA) from the U.S. Food and Drug Administration for a long-acting antibody combination originally developed at Vanderbilt University Medical Center to protect against COVID-19.
Oct. 1, 2021—Vanderbilt research helped allow pharmaceutical giant Merck & Co. to authorization for the first oral antiviral pill to treat COVID-19.
Sep. 29, 2021—Vanderbilt Health has launched a brand communications campaign — called Caregivers Need Care, Too — designed to thank the workforce for their dedication to their patients and to each other during challenging times.
Sep. 27, 2021—Vanderbilt's Meg Rush, MD, MMHC, spoke to several members of Congress recently and painted a vivid picture of the toll the virus has taken on children in Tennessee and at Monroe Carell Jr. Children’s Hospital at Vanderbilt.
Sep. 24, 2021—The City of Tullahoma presented a proclamation of thanks to the staff of Vanderbilt Tullahoma Harton Hospital for their dedicated effort to care for the community during the COVID-19 pandemic.
Sep. 23, 2021—Vanderbilt researchers are studying ways to better evaluate and predict who is at risk of persistent smell and taste loss after COVID-19 infection.
Sep. 22, 2021—Difficult conversations are a hallmark of medicine. Patients and their families rely on us to share the facts about their illnesses that are sometimes hard to hear. While many clinicians begin to do this while training, our effectiveness in these conversations develops throughout a career. Telling a young mother she has an aggressive cancer or...
Sep. 22, 2021—A technology developed at Vanderbilt has led to the discovery of an “ultra-potent” monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta variant.